ORACIT: SODIUM CITRATE AND CITRIC ACID O.
SODIUM CITRATE AND CITRIC ACID O. Key specifications include administration: ORAL, features_provided: UNIT DOSE, primary_container_type: BOTTLE, protective_storage_feature: CONTROLLED ROOM TEMPERATURE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-229-2151, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| special_features | CITRIC ACID 640MG/5ML AND SODIUM CITRATE 490MG/5ML; SOLUTION, CONTAINS PRESERVATIVES; USED FOR TX OF METABOLIC ACIDOSIS; STORE AT CONTROLLED ROOM TEMP 15-30 DEG C DEGC |
| features_provided | UNIT DOSE |
| primary_container_type | BOTTLE |
| protective_storage_feature | CONTROLLED ROOM TEMPERATURE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 30.000 MILLILITERS |
| active_medicament_medicinal_strength | 80.000 MILLIGRAMS SODIUM CITRATE PER MILLILITER AND 128.000 MILLIGRAMS CITRIC ACID PER MILLILITER |
| part_name_assigned_by_controlling_agency | SODIUM CITRIC ACID 640MG/5ML AND SODIUM CITRATE 490MG/5ML SOL 30ML 10S |
| american_hospital_formulary_service_classification_number | 400800 |
| NSN | 6505-01-229-2151 |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | WITH ALCOHOL AND PRESERVATIVES; SHOHLS SOLUTION-ORIGINAL FORMULA |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SODIUM CITRATE AND CITRIC ACID ORAL SOLUTION USP 500ML BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 80.000 MILLIGRAMS SODIUM CITRATE PER MILLILITER AND 128.000 MILLIGRAMS CITRIC ACID PER MILLILITER |